Atlas Trials

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study

Clinical trial NCT02219165 · COMPLETED

Trial details

NCT number
NCT02219165
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Toxic Shock Syndrome
Start date
2015-01-08
Primary completion
2019-04-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.